Haiyan D.

Education: 09/2007-06/2010 M.S. in oncology Medicine, Tumor Hospital, Fudan University, Shanghai, China 09/2002-07/2007 B.S. in Traditional Chinese Medicine, Department of TCM Tianjin University of TCM, Tianjin, China English & Computer skill: College English Test Level-Six, fluency in verbal and written English. Proficiency in office software such as PowerPoint, Excel, Photoshop, SPSS,etc. Work experience: 2007-now Translator (parttime job ) 2009-2010 In charge of filling the Research of mechanisms in the specific effection of differentiations on the pancreatic tumor growth. Specialize in biologic technique such as PCR
Western blot
Elisa and so on. Write the some protocols Editor 06/2008-06/2009 Accomplished clinical round and received favorable comments from doctors I worked with and patients. Mastered the diagnosis and treatment of common diseases Participated in schedule arrangement, data processing and Power Point presentation in the Seminar that is held weekly in our department. Translator for Professor Lisa from MD Anderson Cancer Center, Harvard University Participated in conduct of the phase II clinical trial: Efficacy of Cinobufacini for pancreatic cancer. Familiar with the process and methods of medical study, capable of experiment design and data analysis. 09/2002-06/2007 Practice at the Second Affiliated Hospital, Hospital for Infectious Diseases, NanKai Hospital Techniques & Skills Design clinical trails and write related protocols Writer medical papers and reports Cell Culture (Culturing different kinds of pancreatic cancer cells) PCR, real-time quantitative PCR, Taqman RT-PCR, DNA and RNA extraction, ELISA, Immunohistochemistry, Immunofluorescence, Western-Blotting Publications: P1. Hai-Yan Dai, Peng Wang, Lan-yun Feng, Lu-Ming Liu, Zhi-QiangMeng,Xiao-yan Zhu, Kun Wang,Yong-Qiang, Yi-Xiang Mao, Lian-Yu Chen, Zhen Chen. The molecular mechanism of TCM ZHENG on Pancreatic Tumor Growth. Integrative Cancer Therapies accepted). (Impact Factor: 2.26) P2. SHI Ying-wen; DAI Hai-yan; LIU Lu-ming. A comparison between gemcitabine-based combination chemotherapy and gemcitabine alone on advanced pancreatic cancer:a Meta-analysis in phase b clinical trials. China Oncology. 2008;18(10):913-917. P3. Haiyan Dai, Zhen chen. Targeted therapy of pancreatic cancer. 2010; [login to view URL] P4. Haiyan Dai, Zhen chen. Curcumin on anti-tumor mechanism regulating transcription factor 2010; [login to view URL] Abstracts/Posters/Oral Presentation A1. Haiyan Dai, Zhen chen. The molecular mechanism of TCM ZHENG on Pancreatic Tumor Growth. Integrative Cancer Therapies (05/2010,CACA) A2. Haiyan Dai, Zhen chen. The mechanism of TCM ZHENG on Pancreatic Tumor Growth. Integrative Cancer Therapies (06/2010, National Conference of Integrative Medicine) A3. Haiyan Dai, Zhen chen. The mechanism of TCM ZHENG on Pancreatic Tumor Growth. Integrative Cancer Therapies (09/2010,CSCO)